Chimerix

2005

Chimerix, Inc. Announces Selection As A Top 5 Nominee For 2005 World Technology Award In Health And Medicine    

RESEARCH TRIANGLE PARK, NC, November 10, 2005 - Chimerix, Inc., a biotechnology company developing orally available, targeted medicines to treat smallpox and other viral infections, announced today that the company has been selected as one of the top five nominees… > Read More

Chimerix, Inc. Supports Biodefense Legislation to Accelerate and Innovate Counterterrorism Products    

RESEARCH TRIANGLE PARK, NC, November 3, 2005 - Chimerix, Inc., a biotechnology company developing orally available, targeted medicines to treat smallpox infection and other viral infections, announced today support for S. 1873, the Biodefense and Pandemic Vaccine and Drug Development… > Read More

Chimerix Named a Red Herring Top 100 Private Company    

 - Award Recognizes Chimerix as a Top Company in North America
that Drives the Technology Industry’s Future -

SAN DIEGO, CA, May 12, 2005 - Chimerix Inc., an emerging biotechnology company developing orally available antiviral therapeutics, today… > Read More